For high-throughput transfection of cell lines, e.g.Ba/F3, Raji or THP-1, when working with the 384-well HT Nucleofector® System.
For medium-throughput transfection of cell lines, e.g. Ba/F3, Raji or THP-1, when working with the 4D-Nucleofector® 96-well Unit
For medium-throughput transfection of cell lines, e.g. Ba/F3, Raji or THP-1, when working with the 4D-Nucleofector® 96-well Unit
For high-throughput transfection of cell lines, e.g. Ba/F3, Raji or THP-1, when working with the 384-well HT Nucleofector® System.
Culture system containing RtEBMTM Basal Medium (00195406) and RtEGMTM SingleQuots® Supplements (00195407) required for growth of retinal pigment epithelial cells
For efficient transfection of cell lines, e.g. HepG2, HL-60, Jurkat, K-562 , MCF7, SH-SY5Y, or THP-1, in the NucleofectorTM I/II/2b System
Do you need a quote right away? Add this product to your shopping cart, go to your cart and click on “Generate Quote”. Your quote will be available straight away to view, save online, and download in PDF format.
For efficient transfection of difficult-to-transfect cell lines, e.g. Ba/F3, Raji, or THP-1, in the 4D-Nucleofector® X Unit (20 µL format).
For efficient transfection of difficult-to-transfect cell lines, e.g. Ba/F3, Raji, or THP-1, in the 4D-Nucleofector® X Unit (100 µL format).
For efficient transfection of difficult-to-transfect cell lines, e.g. Ba/F3, Raji, or THP-1, in the 4D-Nucleofector® X Unit (100 µL format).
-
Formulation - RPMI 1640 MediumComposition of RPMI 1640 (12-918)
-
Formulation - RPMI 1640 MediumComposition of RPMI 1640 (04-525)
-
Formulation - RPMI 1640 Medium (12-167, 08-012)Components present in RPMI 1640 (12-167)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 (12-702)
-
Formulation - RPMI 1640 Medium (BE12-702)Components present in RPMI 1640 (BE12-702)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 (12-115)
-
Formulation - RPMI 1640 MediumComponents present in RPMI 1640 Medium (09-774).
-
TechSheet – RPMI 1640 MediumLonza_BenchGuides_RPMI_1640.pdf
-
Webinar – Efficient Transfection of Biologically Relevant Cells in Immunology Research (pdf)Lonza_Webinars_Webinar__Efficient_Transfection_of_Biologically_Relevant_Cells_in_Immunology_Research.pdf
-
Developing Patient-specific Cell Therapy Manufacturing ProcessesPoster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.